Earnings Not Telling The Story For Virbac SA (EPA:VIRP)
Jan 24
Have your own idea? Try our Stock Screener
French (CAC) Healthcare Sector Analysis
UpdatedFeb 01, 2025
DataAggregated Company Financials
Companies64
- 7D4.2%
- 3M12.1%
- 1Y21.6%
- YTD11.6%
In the last week, the Healthcare industry is up 4.2%, with Sanofi up 4.2%. In the last 12 months, the industry was up 19%. As for the next few years, earnings are expected to grow by 10.0% per annum.
Sector Valuation and Performance
Has the French Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Feb 2025 | €318.2b | €110.0b | €10.3b | 20.8x | 30.8x | 2.9x |
| Mon, 30 Dec 2024 | €284.4b | €113.9b | €9.1b | 21.8x | 31.3x | 2.5x |
| Wed, 27 Nov 2024 | €279.0b | €113.9b | €9.1b | 20x | 30.8x | 2.4x |
| Fri, 25 Oct 2024 | €284.4b | €112.5b | €8.8b | 22.3x | 32.3x | 2.5x |
| Sun, 22 Sep 2024 | €284.8b | €112.2b | €8.6b | 21.5x | 33.1x | 2.5x |
| Tue, 20 Aug 2024 | €281.4b | €111.8b | €8.6b | 23.1x | 32.8x | 2.5x |
| Thu, 18 Jul 2024 | €262.5b | €110.1b | €9.0b | 24x | 29x | 2.4x |
| Sat, 15 Jun 2024 | €262.2b | €110.0b | €9.0b | 21.5x | 29.1x | 2.4x |
| Mon, 13 May 2024 | €278.3b | €110.0b | €9.0b | 23.8x | 30.9x | 2.5x |
| Wed, 10 Apr 2024 | €272.1b | €104.7b | €8.5b | 20.5x | 31.9x | 2.6x |
| Fri, 08 Mar 2024 | €271.6b | €104.7b | €8.5b | 21.3x | 31.8x | 2.6x |
| Sun, 04 Feb 2024 | €257.7b | €104.8b | €9.0b | 21.4x | 28.5x | 2.5x |
| Tue, 02 Jan 2024 | €262.1b | €104.0b | €12.7b | 21.6x | 20.6x | 2.5x |
| Thu, 30 Nov 2023 | €248.6b | €104.0b | €12.7b | 20.6x | 19.6x | 2.4x |
| Sat, 28 Oct 2023 | €234.5b | €104.6b | €12.4b | 20.8x | 19x | 2.2x |
| Mon, 25 Sep 2023 | €272.0b | €104.9b | €12.5b | 23.6x | 21.8x | 2.6x |
| Wed, 23 Aug 2023 | €274.5b | €104.5b | €12.5b | 22x | 22x | 2.6x |
| Fri, 21 Jul 2023 | €270.8b | €103.8b | €12.4b | 19.5x | 21.8x | 2.6x |
| Sun, 18 Jun 2023 | €269.6b | €103.8b | €12.4b | 20.4x | 21.7x | 2.6x |
| Tue, 16 May 2023 | €277.7b | €108.3b | €12.1b | 21.3x | 23x | 2.6x |
| Thu, 13 Apr 2023 | €276.8b | €107.9b | €12.4b | 20.3x | 22.4x | 2.6x |
| Sat, 11 Mar 2023 | €258.4b | €107.8b | €12.7b | 19.6x | 20.4x | 2.4x |
| Mon, 06 Feb 2023 | €267.4b | €105.9b | €10.8b | 18.4x | 24.7x | 2.5x |
| Wed, 04 Jan 2023 | €267.4b | €104.9b | €10.5b | 18x | 25.4x | 2.5x |
| Fri, 02 Dec 2022 | €270.1b | €105.1b | €10.5b | 18.6x | 25.8x | 2.6x |
| Sun, 30 Oct 2022 | €256.0b | €104.8b | €10.2b | 17.6x | 25.2x | 2.4x |
| Tue, 27 Sep 2022 | €172.0b | €79.3b | €9.0b | 17x | 19.2x | 2.2x |
| Thu, 25 Aug 2022 | €191.4b | €78.9b | €9.0b | 20.2x | 21.2x | 2.4x |
| Sat, 23 Jul 2022 | €212.2b | €76.6b | €9.1b | 20.7x | 23.4x | 2.8x |
| Mon, 20 Jun 2022 | €194.2b | €76.4b | €9.2b | 18.3x | 21.1x | 2.5x |
| Wed, 18 May 2022 | €209.1b | €75.5b | €9.2b | 19.4x | 22.7x | 2.8x |
| Fri, 15 Apr 2022 | €220.6b | €74.4b | €8.8b | 19.6x | 25.1x | 3x |
| Sun, 13 Mar 2022 | €202.9b | €73.7b | €8.5b | 18.8x | 23.8x | 2.8x |
| Tue, 08 Feb 2022 | €211.3b | €72.4b | €8.6b | 18.8x | 24.6x | 2.9x |
Price to Earnings Ratio
24.6x
Current Industry PE
- Investors are optimistic on the French Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 34.5x which is higher than its 3-year average PE of 25.5x.
- The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 16% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the French Healthcare sector?
| FR Market | 0.38% | |
| Healthcare | 4.18% | |
| Life Sciences | 7.21% | |
| Biotech | 4.24% | |
| Pharma | 4.00% | |
| Medical Equipment | 3.75% | |
| Healthtech | 2.26% | |
| Healthcare Services | 1.72% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 40.6x.
- Analysts are expecting annual earnings growth of 23.2%, which is higher than its past year's earnings decline of 33.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 23% over the next 5 years.
- This is better than its past earnings decline of 34% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings growth to stay flat over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SAN Sanofi | €104.40 | 4.2% +€5.3b | 19.2% | PE22.9x | |
| EL EssilorLuxottica Société anonyme | €265.70 | 3.7% +€4.4b | 47.0% | PE52.8x | |
| DIM Sartorius Stedim Biotech | €223.40 | 7.2% +€1.5b | -8.0% | PE135.4x | |
| ERF Eurofins Scientific | €51.86 | 7.3% +€660.1m | -2.9% | PE24x | |
| BIM bioMérieux | €117.10 | 3.9% +€519.2m | 17.1% | PE33.6x |
